Press – Page 2 – Kiel Pain Clinic

May 6, 2021 May 6, 2021

Cluster headache: Clinical variability, persistent pain between attacks and comorbidity:

A new study from the Kiel Pain Clinic involving 825 patients with cluster headaches shows that cluster headaches can present with considerable clinical variability. The inter- and intra-individual variability of the phenotype can contribute to the fact that the clinical headache phenotype is characterized by [...]

March 30, 2021 March 30, 2021

The AstraZeneca COVID-19 vaccine is now only available for people aged 60 and over

Press release from the STIKO dated March 30, 2021: "The task of the STIKO is to continuously evaluate all scientific data on the efficacy and safety of vaccines and to derive recommendations from them. This naturally also applies when new findings on [...]

August 19, 2020 August 19, 2020

Headache is a widespread disease: one in three of 15 to 19-year-olds suffering from headaches suffers from migraines

Berlin, August 19, 2020. More than one in eight young people in Germany (12.8 percent) suffers from a doctor-diagnosed headache - 15 percent of girls and almost 11 percent of boys. This is a result of the headache report that [...]

July 24, 2020 July 24, 2020

Goodbye headache - The book for children and parents against migraines and headaches

Prof. Dr. Hartmut Göbel Migraines and headaches are a widespread disease. They either put a strain on you. Or you at least know a lot of people around you who suffer from headaches. Even small children can often [...]

July 16, 2020 July 16, 2020

FOCUS Top Medicine 2020 Pain therapy, migraines, headaches, back pain

Prof. Dr. Hartmut Göbel Prof. Dr. med. Hartmut Göbel, head physician at the Kiel Pain Clinic, is one of Germany's top doctors in the field of pain therapy according to the editorial team of Focus Health based on an independent assessment. The [...]

February 29, 2020 February 29, 2020

Application for approval of Emgality® for the prophylaxis of episodic cluster headaches rejected

On Friday, February 27, 2020, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) announced on its website that it recommends rejecting the marketing authorization application for Emgality® (galcanezumab) for the prophylaxis of episodic cluster headache in adults [...]

February 28, 2020 February 28, 2020

Migraine m/f/d

Generations of students have struggled with the problem that a word can have a different gender in different languages. The assignment to female, male or objective gender often seems rather arbitrary. A typical [...]

April 7, 2019 April 7, 2019

Special reprint on the migraine app study 2019

Kiel, April 7, 2019. The current print edition of the scientific journal "Der Schmerz" (Pain) published today features the first scientific analysis of the treatment behavior of migraine and headache patients using digital therapy support with the migraine app. This analysis [...]

January 16, 2019 January 16, 2019

First scientific analysis of the therapy behavior of migraine and headache patients with digital therapy support using the migraine app

Kiel, January 16, 2019. The journal *Der Schmerz* (Pain) published today the first scientific analysis of the treatment behavior of migraine and headache patients using digital therapy support with the migraine app. This is the first scientific publication on the application [...]

January 13, 2019 January 13, 2019

NICE: Erenumab for preventing migraines is not cost-effective, says draft guidelines

London, 10 January 2019. The National Institute for Health and Care Excellence (NICE) is assessing guidance on health technologies, clinical practice and prevention for the UK Department of Health. The [...]

October 26, 2018 October 26, 2018

Prevent migraine attacks with immunotherapy

The diseases headache and migraine not only affect the lives of those affected, but also cause economic damage. Newly developed antibodies intervene specifically in the molecular development process of migraines and can therefore preventively reduce the likelihood [...]

September 3, 2018 September 3, 2018

Migraine Awareness Week 2018 – Migraine Awareness Week 2018

The first week of September is used internationally to educate people about migraines in order to raise awareness of the great importance of the health problem. Prejudices and stigmas should be reduced. Prof. Hartmut Göbel answers current questions about migraines, their effects [...]

August 1, 2018 August 1, 2018

High honors for Bettina Frank for her commitment to self-help. She was awarded the Federal Cross of Merit 1st Class by Federal President Steinmeier

Kiel, August 1st, 2018. The Prime Minister of Schleswig-Holstein, Daniel Günther, presented today in the presence of the Minister of Health Dr. Heiner Garg and district president Dr. Juliane Rumpf and numerous guests of honor received the Cross of Merit 1st awarded to her by Federal President Frank-Walter Steinmeier.

July 30, 2018 July 30, 2018

EU Commission approves approval for erenumab (Aimovig)

July 30, 2018. The migraine immunotherapy with the active ingredient erenumab (Aimovig) can now also be sold in the EU. The US approval was initially given in May 2018, followed by approval in Switzerland in July. Now the [...]

July 16, 2018 July 16, 2018

FAZ study “Germany’s best hospitals”: Kiel Pain Clinic ranked at the top among pain clinics nationwide and in the top 10 of all around 2,000 clinics regardless of specialty

In the FAZ study "Germany's best hospitals", the Kiel pain clinic takes on the top position among the specialized inpatient pain therapy clinics nationwide. In relation to all around 2000 hospitals in Germany, she was among the 10 best clinics [...]

26 ,

Headache of the voltage type: Local topical treatment with peppermint oil (oleum menthae piperitae)

Tension-type headaches are the most common type of headache. Local topical treatment with peppermint oil (Oleum menthae piperitae) has proven significantly effective compared to placebo in controlled studies. Peppermint oil acts through numerous mechanisms of action [...]

April 17, 2018 April 17, 2018

Doc Esser: Dr. Heinz-Wilhelm Esser meets headache patients

Headaches are a common problem. 54 million people in Germany are affected. Dr. Heinz-Wilhelm Esser meets headache patients. During his visit to the Kiel Pain Clinic, he found out about, among other things, the causes of migraines and headaches, [...]

April 6, 2018 April 6, 2018

The complete click-tips series for the migraine app by Prof. Hartmut Göbel

In these click tips, Prof. Hartmut Göbel from the Kiel Pain Clinic shows you how the migraine app analyzes the course of treatment individually, supports and optimizes the treatment. In the list below you will find the complete series of all [...]

March 30, 2018 March 30, 2018

Use the migraine app to simulate, understand and specifically treat a migraine aura live.

With the current update of the migraine app from the Kiel Pain Clinic and the Techniker Krankenkasse (TK), many new functions are available. These are intended to help those affected to better classify headache attacks and to distinguish them from other neurological diseases.

March 19, 2018 March 19, 2018

Ibuprofen in the first three months of pregnancy could have harmful effects on the fertility of the daughters

Approximately 30% of pregnant women take the pain reliever ibuprofen during the first three months of pregnancy. Ibuprofen works by inhibiting prostaglandin synthesis. It has long been known that this can impair pregnancy and/or embryo-fetal development [...]